札幌臨床検査センターの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/16 | 1,055 | 1,055 | 1,007 | 1,013 | -42 | -4% | 3,200 |
| 2024/05/15 | 1,061 | 1,061 | 1,055 | 1,055 | -20 | -1.9% | 1,500 |
| 2024/05/14 | 1,080 | 1,080 | 1,061 | 1,075 | -6 | -0.6% | 4,100 |
| 2024/05/13 | 1,088 | 1,088 | 1,081 | 1,081 | -15 | -1.4% | 300 |
| 2024/05/10 | 1,087 | 1,096 | 1,083 | 1,096 | - | - | 2,600 |
| 2024/05/09 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2024/05/08 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2024/05/07 | 1,115 | 1,115 | 1,104 | 1,104 | +4 | +0.4% | 700 |
| 2024/05/02 | 1,106 | 1,128 | 1,082 | 1,100 | +24 | +2.2% | 5,400 |
| 2024/05/01 | 1,076 | 1,076 | 1,076 | 1,076 | +6 | +0.6% | 100 |
| 2024/04/30 | 1,082 | 1,082 | 1,070 | 1,070 | -10 | -0.9% | 1,600 |
| 2024/04/26 | 1,081 | 1,081 | 1,080 | 1,080 | ±0 | ±0% | 300 |
| 2024/04/25 | 1,080 | 1,080 | 1,080 | 1,080 | -2 | -0.2% | 100 |
| 2024/04/24 | 1,080 | 1,091 | 1,080 | 1,082 | -2 | -0.2% | 800 |
| 2024/04/23 | 1,084 | 1,092 | 1,084 | 1,084 | +10 | +0.9% | 300 |
| 2024/04/22 | 1,092 | 1,092 | 1,074 | 1,074 | -17 | -1.6% | 1,100 |
| 2024/04/19 | 1,091 | 1,091 | 1,090 | 1,091 | -16 | -1.4% | 800 |
| 2024/04/18 | 1,110 | 1,110 | 1,091 | 1,107 | -4 | -0.4% | 1,300 |
| 2024/04/17 | 1,080 | 1,111 | 1,078 | 1,111 | +41 | +3.8% | 1,100 |
| 2024/04/16 | 1,079 | 1,079 | 1,070 | 1,070 | -7 | -0.6% | 1,100 |
| 2024/04/15 | 1,077 | 1,077 | 1,077 | 1,077 | - | - | 300 |
| 2024/04/12 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2024/04/11 | 1,090 | 1,090 | 1,081 | 1,082 | -2 | -0.2% | 900 |
| 2024/04/10 | 1,084 | 1,084 | 1,084 | 1,084 | -3 | -0.3% | 100 |
| 2024/04/09 | 1,077 | 1,097 | 1,077 | 1,087 | +10 | +0.9% | 700 |
| 2024/04/08 | 1,077 | 1,078 | 1,077 | 1,077 | +1 | +0.1% | 400 |
| 2024/04/05 | 1,069 | 1,076 | 1,069 | 1,076 | +1 | +0.1% | 300 |
| 2024/04/04 | 1,075 | 1,075 | 1,075 | 1,075 | +4 | +0.4% | 300 |
| 2024/04/03 | 1,082 | 1,082 | 1,070 | 1,071 | -9 | -0.8% | 600 |
| 2024/04/02 | 1,100 | 1,100 | 1,080 | 1,080 | -7 | -0.6% | 1,200 |
| 2024/04/01 | 1,101 | 1,101 | 1,086 | 1,087 | +1 | +0.1% | 300 |
| 2024/03/29 | 1,097 | 1,100 | 1,081 | 1,086 | -11 | -1% | 1,200 |
| 2024/03/28 | 1,079 | 1,099 | 1,079 | 1,097 | +9 | +0.8% | 1,100 |
| 2024/03/27 | 1,080 | 1,095 | 1,080 | 1,088 | +13 | +1.2% | 1,400 |
| 2024/03/26 | 1,078 | 1,087 | 1,070 | 1,075 | -3 | -0.3% | 2,100 |
| 2024/03/25 | 1,079 | 1,089 | 1,078 | 1,078 | ±0 | ±0% | 2,600 |
| 2024/03/22 | 1,070 | 1,093 | 1,065 | 1,078 | +8 | +0.7% | 5,400 |
| 2024/03/21 | 1,065 | 1,084 | 1,065 | 1,070 | +9 | +0.8% | 5,100 |
| 2024/03/19 | 1,050 | 1,068 | 1,050 | 1,061 | +11 | +1% | 2,100 |
| 2024/03/18 | 1,032 | 1,050 | 1,032 | 1,050 | +20 | +1.9% | 2,900 |
| 2024/03/15 | 1,053 | 1,053 | 1,030 | 1,030 | -29 | -2.7% | 2,100 |
| 2024/03/14 | 1,008 | 1,059 | 1,005 | 1,059 | +52 | +5.2% | 8,600 |
| 2024/03/13 | 1,004 | 1,009 | 1,004 | 1,007 | +1 | +0.1% | 700 |
| 2024/03/12 | 1,005 | 1,006 | 1,005 | 1,006 | +1 | +0.1% | 200 |
| 2024/03/11 | 1,007 | 1,008 | 1,005 | 1,005 | -2 | -0.2% | 1,200 |
| 2024/03/08 | 1,009 | 1,012 | 1,007 | 1,007 | -4 | -0.4% | 700 |
| 2024/03/07 | 1,012 | 1,015 | 1,009 | 1,011 | -1 | -0.1% | 1,700 |
| 2024/03/06 | 1,010 | 1,019 | 1,010 | 1,012 | +2 | +0.2% | 1,400 |
| 2024/03/05 | 1,013 | 1,019 | 1,010 | 1,010 | -7 | -0.7% | 1,800 |
| 2024/03/04 | 1,015 | 1,017 | 1,009 | 1,017 | -2 | -0.2% | 3,400 |
1～
50
件表示中 / 3456件
類似銘柄と比較する
現在ご覧いただいている「札 臨」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 札 臨 | 100,000円 | +0.6% | -4.1% | 2.30% | 9.75倍 | 0.29倍 |
|
臨床検査、調剤薬局を展開。Ｈ．Ｕ．グループで受託臨床検査首位のエスアールエルと提携 |
| イーサポート | 98,500円 | +21.9% | +42.1% | 0.51% | 57.33倍 | 1.28倍 |
|
生鮮青果物業界向け物流システム開発。イオングループ向けを一手に受託。農業支援事業も展開 |
| ＳＭＮ | 29,700円 | +7.1% | +36.8% | 0.00% | 108.00倍 | 1.18倍 |
|
ソニーグループ系。ネット広告配信を最適化するアドテク事業や成果報酬型広告運営で稼ぐ |
| ダイサン | 56,000円 | -1.6% | - | 3.93% | - | 0.67倍 |
|
住宅・建築工事の足場設計・施工業者。くさび式で首位。関東圏を拡充。シンガポールに拠点 |
| 総医研 | 16,500円 | -29.0% | - | 3.03% | - | 0.68倍 |
|
抗疲労食品・飲料の直販と中国ＥＣ主体の化粧品販売が収益柱。評価試験や医薬品臨試受託も |
市場注目の銘柄
チャート関連のコラム
